As the medical device industry transitions to a highly consumer-driven marketplace, incorporating user feedback into new ...

Samsung's venture arm is looking to invest in California-based medical device startup Exo, Bloomberg reported.

On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns about its Spine business. The analyst did not assign a price target following ...

Thornal will join the orthopedics company as group president for global businesses and the Americas, a newly created position.

Fintel reports that on May 27, 2025, BTIG downgraded their outlook for Globus Medical (NYSE:GMED) from Buy to Neutral.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $77.5, a high ...

BTIG analysts have downgraded (NYSE:GMED) from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

Chester County Futures (CCF), in collaboration with Globus Medical, recently provided a transformative learning experience ...